#AACR26:
@washumedicine
radiation oncologist Carl DeSelm, MD, PhD, shares insights into tumor-reactive T cells during his
@AACR
presentation, “A novel, first in class chimeric antigen receptor dendritic cell platform driving broad and durable antitumor immunity in solid tumors.”